HIV News and Research

RSS

Penis microbiome is reservoir for bacterial vaginosis-associated bacteria

Previous studies have pointed out that the reproductive microbiomes of partners might be exchanged in bacterial vaginosis (BV). Now, a team of researchers at the University of Illinois in Chicago compared the microbiota of couples before and after the development of BV.

4 Aug 2020

Study shows high SARS-CoV-2 seroprevalence, but low death rate in Malawi's health care workers

A study by researchers from Malawi and United Kingdom reveals a significant discrepancy between predicted coronavirus disease (COVID-19) mortality in the observed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence rates in health care workers and reported deaths in urban Malawi in southeastern Africa, indicating early exposure, but a slow progression of the outbreak. Their findings are currently available on the medRxiv preprint server.

3 Aug 2020

SARS-CoV-2 lured away and trapped by a new decoy version of ACE2

Researchers in the United States and Canada have engineered affinity-optimized “receptor traps” that prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from binding to and infecting cells.

3 Aug 2020

Stabilized prefusion spike vaccine candidate induces powerful immune response

A new research paper by scientists at Janssen Vaccines & Prevention BV, in the Netherlands and published on the preprint server bioRxiv* is based on the assumption that an effective vaccine against these infections will induce neutralizing antibodies and an immune response favoring Th1 immunity.

3 Aug 2020

SARS-CoV-2 spike protein recognized by innate immune receptors in a glycan-dependent way

The spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) depends on its ability to infect new host cells following its replication and release from infected cells. This pivots on its ability to bind to cell surface receptors like the ACE2 enzyme.

3 Aug 2020

There could be 7 million unplanned pregnancies because of COVID-19

The coronavirus pandemic has rippled across the globe, infecting nearly 18 million individuals worldwide to date. Though the coronavirus disease (COVID-19) affects people from all walks of life, women and girls may experience devastating effects of the outbreak.

2 Aug 2020

War of sugars - estrogen provides protection in COVID-19

Now a new study published on the preprint server bioRxiv in July 2020 reports that sex hormones could affect the function of the fusion protein that is dependent upon the human ACE2 receptor, thus preventing the entry of the virus into the host cell.

31 Jul 2020

UOttawa's Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists

The Faculty of Medicine has awarded 58 clinical research chairs to top clinician-scientists in a five-year, $40 million investment to drive clinical research excellence and enhance health and patient care.

30 Jul 2020

Anti-inflammatory Tetracycline activity may modulate COVID-19 severity

The current COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), seems to attack the human airway epithelium primarily. In severely affected patients, the illness progresses to hypoxemic respiratory failure and acute respiratory distress syndrome (ARDS). The latter is treatable mainly by supportive management.

30 Jul 2020

Pilot study shows cholesterol-lowering medication improves function of coronary arteries

In a pilot study of people living with HIV or high levels of cholesterol, Johns Hopkins Medicine researchers found that a six-week course of a cholesterol-lowering medication improved the function of the coronary arteries that provide oxygen to the heart.

29 Jul 2020

Study: HIV, TB, and malaria deaths could increase in low- and middle-income countries

Low- and middle-income countries could see HIV, tuberculosis (TB), and malaria deaths increase by up to 36 per cent over the next five years because of COVID-19-induced health services disruptions, a study projects.

29 Jul 2020

Study reveals multiple characteristics of HIV-1-producing cells in vivo

For eradication of HIV-1 infection, it is important to elucidate the detailed features and heterogeneity of HIV-1-infected cells in vivo.

29 Jul 2020

Fighting a pandemic is 500 times more expensive than the costs of preventive efforts

According to new research, the failure to protect tropical rain forests has cost trillions of dollars stemming from the coronavirus pandemic, which has wreaked economic havoc and caused historic levels of unemployment in the United States and around the world.

28 Jul 2020

ECDC and WHO collaborate to track the status of hepatitis infections across EU

Approximately four in five people living with hepatitis B and three out of four people with hepatitis C infection across the European Union and European Economic Area (EU/EEA) and the UK have not yet been diagnosed.

28 Jul 2020

GW to participate in a clinical trial for investigational COVID-19 vaccine

The George Washington University today announced that it will participate in a clinical trial for an investigational COVID-19 vaccine.

27 Jul 2020

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

A vaccine candidate for preventing COVID-19 is advancing to a 30,000-participant phase 3 trial that begins today, and Brigham and Women's Hospital will play two key roles in the trial's next phase.

27 Jul 2020

NIDA funding allows Temple scientists to continue critical substance abuse research

Substance abuse is a major public health problem in the United States, with some 21 million Americans diagnosed with at least one substance use disorder.

27 Jul 2020

The color of COVID: Will vaccine trials reflect America’s diversity?

When U.S. scientists launch the first large-scale clinical trials for COVID-19 vaccines this summer, Antonio Cisneros wants to make sure people like him are included.

27 Jul 2020

Face masks do not lead to false sense of security, shows study

Existing limited evidence suggests that wearing face coverings to protect against COVID-19 does not lead to a false sense of security and is unlikely to increase the risk of infection through wearers foregoing other behaviours such as good hand hygiene, say researchers from the University of Cambridge and King's College London.

27 Jul 2020

National clinical trial to test potential vaccine against SARS-CoV-2

UC San Diego Health and the Altman Clinical and Translational Research Institute, part of UC San Diego School of Medicine, will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the novel coronavirus that causes COVID-19.

25 Jul 2020

HIV News and Research

Penis microbiome is reservoir for bacterial vaginosis-associated bacteria

Study shows high SARS-CoV-2 seroprevalence, but low death rate in Malawi's health care workers

SARS-CoV-2 lured away and trapped by a new decoy version of ACE2

Stabilized prefusion spike vaccine candidate induces powerful immune response

SARS-CoV-2 spike protein recognized by innate immune receptors in a glycan-dependent way

There could be 7 million unplanned pregnancies because of COVID-19

War of sugars - estrogen provides protection in COVID-19

UOttawa's Faculty of Medicine awards 58 clinical research chairs to top clinician-scientists

Anti-inflammatory Tetracycline activity may modulate COVID-19 severity

Pilot study shows cholesterol-lowering medication improves function of coronary arteries

Study: HIV, TB, and malaria deaths could increase in low- and middle-income countries

Study reveals multiple characteristics of HIV-1-producing cells in vivo

Fighting a pandemic is 500 times more expensive than the costs of preventive efforts

ECDC and WHO collaborate to track the status of hepatitis infections across EU

GW to participate in a clinical trial for investigational COVID-19 vaccine

Brigham to play two key roles in phase 3 trial of COVID-19 vaccine candidate

NIDA funding allows Temple scientists to continue critical substance abuse research

The color of COVID: Will vaccine trials reflect America’s diversity?

Face masks do not lead to false sense of security, shows study

National clinical trial to test potential vaccine against SARS-CoV-2

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News